ISSN: 0735-7907

Journal Home

Journal Guideline

Cancer Investigation Q2 Unclaimed

Informa Healthcare United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Investigation is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 93. It has an SJR impact factor of 0,604 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,604.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q2) Cancer Research (Q3) Oncology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,604

SJR Impact factor

93

H Index

83

Total Docs (Last Year)

247

Total Docs (3 years)

3668

Total Refs

452

Total Cites (3 years)

229

Citable Docs (3 years)

1.77

Cites/Doc (2 years)

44.19

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Cell Density-Dependent Proliferative Effects of Transforming Growth Factor (TGF)-beta1, beta2, and beta3 in Human Chondrosarcoma Cells HCS-2/8 Are Associated with Changes in the Expression of TGF-beta Receptor Type I

Ovarian Cancer: Review of the National Institute for Clinical Excellence (NICE) Guidance Recommendations

Clinical Course and Pathologic Findings After Gliadel¬Æ and Radiotherapy for Newly Diagnosed Malignant Glioma: Implications for Patient Management

Effect of Hyperthermia on AKR Lymphoma Variants Differing in Degree of Malignancy

Does99mTc-Sestamibi Uptake Discriminate Breast Tumors?

Development of QSAR Models to Predict Estrogenic, Carcinogenic, and Cancer Protective Effects of Phytoestrogens

Economic Analysis of Amifostine as Adjunctive Support for Patients with Advanced Head and Neck Cancer: Preliminary Results from a Randomized Phase II Clinical Trial from Germany

Capecitabine: Fixed Daily Dose and Continuous (Noncyclic) Dosing Schedule

Clues to the Etiology of Childhood Brain Cancer: N-Nitroso Compounds, Polyomaviruses, and Other Factors of Interest

Comparison of Conventional Dose and Double Dose Carboplatin in Patients Receiving Cyclophosphamide Plus Carboplatin for Advanced Ovarian Carcinoma: A North Central Cancer Treatment Group Study

Hepatic Arterial Infusion of Paclitaxel for Liver Metastasis from Gastric Cancer

Facing Erectile Dysfunction Due to Prostate Cancer Treatment: Perspectives of Men and Their Partners

SHOW MORE ARTICLES

Quality Improvement Efforts in Oncology: Are We Ready to Begin?

Gemcitabine Combined with Docetaxel for the Treatment of Unresectable Pancreatic Carcinoma

Detection of Recurrent Nasopharyngeal Carcinomas After Radiotherapy with Technetium-99m Tetrofosmin Single Photon Emission Computed Tomography in Patients with Indeterminate Magnetic Resonance Imaging Findings

Long-Term Effects on the Intelligence of Children Treated for Acute Lymphoblastic Leukemia

8-Cl-cAMP Affects Glioma Cell-Cycle Kinetics and Selectively Induces Apoptosis

Applications of Image Analysis to Anatomic Pathology: Realities and Promises

Common Variable Immunodeficiency and Breast Cancer

How Should We Manage Patients with "Platinum-Sensitive" Recurrent Ovarian Cancer?

A Preliminary Study of CA15-3, c-erbB-2, Epidermal Growth Factor Receptor, Cathepsin-D, and p53 in Saliva Among Women with Breast Carcinoma

Effect of TNP-470 (AGM-1470) on the Growth of Rat Rhabdomyosarcoma Tumors of Different Sizes

Breast Cancer Control and African American Women: A Review*

Targeted Therapy in Cancer and Transgenic Animal Model